Register entry
MIPS Cyclotron & Radiochemistry Facility
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Fludeoxyglucose F18 | Fludeoxyglucose F18 | injection, intravenous | 69587-001ANDA |
Compare
Other companies listing fludeoxyglucose f18
- The University of Texas MD Anderson Cancer Center2 sites · 1 NDC
- 3D Imaging Drug Design and Development1 site · 3 NDC
- Kreitchman PET Center1 site · 3 NDC
- UCSF Radiopharmaceutical Facility1 site · 3 NDC
- The Methodist Hospital Research Institute1 site · 2 NDC
- The Regents of the University of Michigan1 site · 1 NDC
Enquiry
Common questions
- Is MIPS Cyclotron & Radiochemistry Facility FDA approved?
- MIPS Cyclotron & Radiochemistry Facility holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does MIPS Cyclotron & Radiochemistry Facility make?
- 1 product is listed under MIPS Cyclotron & Radiochemistry Facility in the openFDA NDC Directory, most often as injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.